TacticScaleWhat Warby Parker Does & How It Makes Money (WRBY)
Updated October 2026 · reflects Warby Parker's latest reported financials
Direct-to-consumer eyewear brand selling glasses, sunglasses, and contacts. It makes money mainly by selling its eyeglasses, sunglasses, lenses, and accessories directly to consumers through its own stores and online channels.
How Warby Parker makes money
It makes money mainly by selling its eyeglasses, sunglasses, lenses, and accessories directly to consumers through its own stores and online channels. Eye exams and other optical services bring in more revenue and help drive product sales.
What Warby Parker does
Warby Parker Inc. is a direct-to-consumer eyewear company headquartered in New York. Since it was incorporated in 2009, it has sold eyeglasses, sunglasses, and contact lenses to customers in the United States and Canada through its own retail stores, website, and mobile apps. Its lenses include single-vision, progressive, light-responsive, polarized, blue-light-filtering, tinted, and non-prescription options. Beyond eyewear, the company offers eye exams, vision tests, and optical services, so customers can get a prescription and buy glasses from the same brand. It also sells accessories such as cases, pouches, lens cloths, anti-fog spray, and sun clip-ons. Because it sells both in stores and online, it can reach customers wherever they prefer to shop.
Products & services
- Prescription eyeglasses
- Sunglasses
- Progressive and specialty lenses (light-responsive, polarized, blue-light-filtering)
- Contact lenses
- Eye exams and vision tests
- Eyewear accessories (cases, lens cloths, anti-fog spray, sun clip-ons)
What is Warby Parker worth?
On an owner-earnings DCF, Warby Parker's most-likely value is about $12 versus a recent price near $25 (54% above fair value). But TacticScale only calls a stock undervalued when the price sits below its conservative no-growth floor (~$3) with a margin of safety — so the honest verdict here is “Fairly priced — no edge.” Fair value earns its keep only at the extremes, not in the wide middle.
Price sits in the normal range — fair value isn't actionable here; it earns its keep only when price drops below the no-growth floor, or runs to roughly double the optimistic case.
Analysis, not advice. Fair value is a margin-of-safety estimate from a deterministic owner-earnings DCF, not a price target or recommendation. See the full breakdown →
Related companies
National Vision (EYE) · The Cooper Companies (COO) · Eyebright Medical Technology (Beijing) (688050.SS) · STAAR Surgical (STAA)